Why is Sotac Pharma. falling/rising?

As of 04-Jul, Sotac Pharmaceuticals Ltd is currently priced at 136.60, with no change in price (0.00%). The stock has underperformed its sector by 0.51% today, and its delivery volume has significantly decreased by 94.62% compared to the 5-day average, indicating falling investor participation. Over the past week, the stock has declined by 1.16%, while it has shown a positive return of 8.46% over the past month. Despite a year-to-date return of 24.98%, the stock has underperformed over the last year with a return of -2.43%. The company has an attractive valuation with a return on capital employed (ROCE) of 8.1 and a low PEG ratio of 0.4, suggesting that while profits have risen by 79%, the stock's recent performance may not fully reflect this improvement.
In the broader market context, the Sensex has decreased by 0.69% over the past week, indicating that the stock's short-term decline is somewhat aligned with the market trend. However, Sotac Pharmaceuticals' performance over the last month has outpaced the benchmark, which has only increased by 3.42%. This suggests that while the stock is facing some challenges in the short term, its longer-term performance remains strong relative to the market, particularly in the context of its significant year-to-date gains.